Tag
GlaxoSmithKline
China’s Demographic Dividend Could End By 2015
Plus, more damning reports on British drugmaker GlaxoSmithKline’s activities in China. Tuesday China links.
Xi’s Anti-Graft Campaign: Politics as Usual?
While success is possible, China’s current anti-corruption campaign is most likely old wine in a new bottle.
Page 1 of 1